Bandy-Plus Chewable Tablet is used in the treatment of worm infections, including those caused by roundworms, hookworms, and tapeworms. Discover Bandy-Plus Chewable Tablet's uses, dosage, side effects, composition, safety tips, interactions, and expert advice.
🟢 Bandy-Plus Chewable Tablet – Combat parasitic infections easily with this single-dose chewable!
💊 Type: Prescription Medicine
🏢 Manufacturer: Mankind Pharma Ltd
🧪 Composition: Ivermectin (6mg) + Albendazole (400mg)
🌡️ Storage: Store below 30°C in a cool, dry place
🔁 Similar Medicines: [Click here to view substitutes]
Bandy-Plus Chewable Tablet is a powerful dual-action antiparasitic medication combining two potent active ingredients: Ivermectin (6mg) and Albendazole (400mg). This combination formulation is specifically designed to combat a wide spectrum of parasitic infections affecting humans, providing comprehensive coverage against both intestinal helminths (worms) and ectoparasites (external parasites).
The strategic combination of Ivermectin and Albendazole in Bandy-Plus Chewable Tablet offers a synergistic approach to parasite elimination. Albendazole primarily targets intestinal worms such as roundworms, hookworms, whipworms, and certain tapeworms, while Ivermectin is particularly effective against threadworms (strongyloidiasis), as well as ectoparasites like scabies mites and head lice. Together, they provide a broad-spectrum antiparasitic effect that is especially valuable in regions where polyparasitism (infection with multiple parasite types) is common.
This chewable formulation has been developed to enhance patient compliance, particularly in pediatric populations and communities where regular administration of antiparasitic medication is part of public health programs. The chewable nature of the tablet eliminates the need for water during administration, making it convenient for use in diverse settings, including areas with limited access to clean water.
Bandy-Plus Chewable Tablet is typically prescribed for the treatment of mixed parasitic infections, during community-wide deworming programs, or in cases where a patient is suspected to harbor multiple types of parasites. The medication's dual mechanism of action not only works to eliminate existing parasites but also helps prevent reinfection during the treatment period by targeting different developmental stages of the parasites.
It's worth noting that this combination therapy is generally reserved for specific clinical scenarios and is usually prescribed by healthcare professionals specialized in infectious diseases or tropical medicine. Due to the potency of both active ingredients, Bandy-Plus Chewable Tablet is typically administered under medical supervision, following appropriate diagnosis and weight-based dosing considerations, especially in mass drug administration programs for neglected tropical diseases.
Active Ingredients:
Ivermectin 6mg
Albendazole 400mg
Inactive Ingredients: May include:
Microcrystalline cellulose
Lactose monohydrate
Magnesium stearate
Colloidal silicon dioxide
Sodium starch glycolate
Artificial flavors (often fruit flavors)
Sweeteners (such as sucralose or aspartame)
Colorants (such as titanium dioxide)
Treatment of mixed intestinal helminth infections
Management of strongyloidiasis (threadworm infection)
Treatment of ascariasis (roundworm infection)
Management of hookworm infections (Necator americanus, Ancylostoma duodenale)
Treatment of trichuriasis (whipworm infection)
Management of enterobiasis (pinworm infection)
Treatment of scabies infestation
Management of head lice infestation
Treatment of certain tissue nematode infections
Part of lymphatic filariasis control programs
Treatment of cutaneous larva migrans
Management of neurocysticercosis (in specific cases)
Control of onchocerciasis (river blindness) in endemic areas
Part of community-wide deworming programs in endemic regions
Provides broad-spectrum coverage against various parasitic infections
Combines two complementary antiparasitic mechanisms for enhanced efficacy
Single-dose treatment effective for many common parasitic infections
Chewable formulation improves compliance, especially in children
Can be taken without water, convenient for various settings
Eliminates the need for multiple different antiparasitic medications
Particularly valuable in regions with high polyparasitism prevalence
Effective against both intestinal and tissue-dwelling parasites
Helps reduce the overall parasite burden in endemic communities
May help prevent reinfection during the treatment period
Cost-effective approach for comprehensive parasite control
Suitable for mass drug administration programs in endemic areas
Bandy-Plus Chewable Tablet combines two antiparasitic agents with different mechanisms of action:
Ivermectin (6mg):
Binds selectively to glutamate-gated chloride ion channels found in invertebrate nerve and muscle cells
This binding causes increased permeability to chloride ions, resulting in hyperpolarization of the nerve or muscle cell
The hyperpolarization paralyzes and kills the parasite
Particularly effective against nematodes and arthropods
Has limited penetration across the blood-brain barrier in humans at therapeutic doses
Also disrupts the reproduction cycle of certain parasites
Albendazole (400mg):
Selectively binds to beta-tubulin in parasitic cells
Inhibits microtubule polymerization, preventing glucose uptake in the helminth
This leads to glycogen depletion, decreased ATP formation, and eventually immobilization and death of the parasite
Also blocks egg production in female worms
Undergoes first-pass metabolism in the liver to form albendazole sulfoxide, the active metabolite
Effective against both larval and adult stages of many helminths
The combination provides complementary coverage:
Ivermectin primarily targets certain nematodes and ectoparasites
Albendazole is effective against a broad range of intestinal helminths
Together, they address most major human parasitic infections with a single formulation
For intestinal helminth infections in adults and children >15kg:
Typically a single dose based on weight
Usually one tablet (Ivermectin 6mg + Albendazole 400mg) as a single dose
May be repeated after 2-4 weeks in heavy infections
For scabies:
Single dose, often repeated after 7-14 days
Weight-based dosing may be required for children:
Healthcare providers should determine appropriate dosing for children based on weight
Tablet may need to be divided for children under certain weight thresholds
For mass drug administration programs:
Follows specific protocols established by health authorities
Typically administered once or twice yearly
As treatment is usually a single dose, the concept of missed doses typically doesn't apply
If a scheduled repeated dose is missed, take it as soon as remembered unless it's close to the next scheduled dose
Consult healthcare provider for guidance if unsure
Symptoms may include nausea, vomiting, diarrhea, hypotension, ataxia, and seizures
Seek immediate medical attention if overdose is suspected
Treatment is supportive and symptomatic
Chew the tablet thoroughly before swallowing
Can be taken with or without food, though taking with food may improve tolerance
For children who cannot chew, the tablet may be crushed and mixed with a small amount of soft food
Take the full prescribed dose at one time unless otherwise directed by your healthcare provider
Wash hands thoroughly before and after taking the medication, especially when treating scabies or other contagious parasites
Follow any specific instructions provided by your healthcare provider regarding isolation or sanitation measures during treatment
For optimal results, all household members may need treatment simultaneously when dealing with highly contagious parasites like scabies
Headache
Dizziness
Nausea or vomiting
Abdominal pain
Diarrhea
Transient fever
Itching or rash
Elevated liver enzymes
Joint or muscle pain
Fatigue
Increased heart rate
Dizziness upon standing (orthostatic hypotension)
Temporary hair loss
Severe skin reactions
Neurological effects (seizures, confusion)
Significant drop in blood pressure
Mazzotti reaction (in patients with onchocerciasis)
Blood disorders
Liver injury
Most mild side effects resolve within a few days without intervention
Stay hydrated to help manage gastrointestinal side effects
Antihistamines may help relieve itching (consult healthcare provider)
Over-the-counter pain relievers may help with headache or mild pain
For parasitic die-off reactions, rest and supportive care are recommended
Report severe or persistent side effects to your healthcare provider immediately
CAUTION: Avoid alcohol during treatment and for a few days after, as it may increase the risk of side effects, particularly liver-related adverse effects.
UNSAFE: Not recommended during pregnancy, especially during the first trimester. Use only if clearly needed and the potential benefit justifies the potential risk to the fetus.
CAUTION: Ivermectin is excreted in breast milk. Consider temporarily suspending breastfeeding for 1-2 days after treatment or use an alternative medication if possible.
CAUTION: May cause dizziness or visual disturbances in some individuals. Assess your response to the medication before driving or operating machinery.
CAUTION: No specific dose adjustment required for mild to moderate impairment, but use cautiously in severe kidney disease. Consult your doctor.
CAUTION: Both active ingredients are metabolized by the liver. Use with caution in patients with liver disease; dose adjustments or monitoring may be required.
CAUTION: Safety and efficacy in children weighing less than 15kg have not been well established. Weight-based dosing is critical. Use only under medical supervision.
CAUTION: May be more sensitive to side effects. Monitor closely, especially for neurological adverse effects.
CONTRAINDICATED: Do not use if allergic to ivermectin, albendazole, or any component of the formulation.
Mazzotti Reaction: Patients with onchocerciasis may experience severe reactions due to parasite die-off
CNS Effects: May cause neurological side effects, especially at higher doses
Liver Function: Periodic monitoring of liver function may be necessary with prolonged use
Blood Disorders: Rare cases of blood disorders have been reported; monitoring may be advised
Ocular Effects: Rare reports of eye irritation, redness, or visual changes
Enhanced Drug Effect: Certain conditions may increase blood levels of either component
Drug Interactions: Several significant drug interactions may occur
Specific Helminth Infections: May not be appropriate for all types of helminth infections
Self-Medication: Should not be used for self-medication without proper diagnosis
Reinfection: Environmental measures should be implemented to prevent reinfection
Resistance Development: Inappropriate use may contribute to parasite resistance
Warfarin: May enhance anticoagulant effect; monitor INR closely
Anticonvulsants: May alter levels of both drugs; monitor for efficacy and side effects
Cimetidine: May increase albendazole levels
Dexamethasone: May increase albendazole levels
HIV Protease Inhibitors: May increase ivermectin levels
Barbiturates: May decrease albendazole effectiveness
Rifampin: May decrease albendazole levels
Other antiparasitic medications: May have additive toxicity
P-glycoprotein inhibitors: May increase ivermectin levels
Fatty meals: Taking with fatty foods may increase absorption, particularly of albendazole
Grapefruit juice: May theoretically affect metabolism; best avoided during treatment
Alcohol: May increase the risk of liver-related side effects
Hypersensitivity to ivermectin, albendazole, or any component of the formulation
Pregnancy (especially first trimester)
Children weighing less than 15kg (unless specifically directed by a specialist)
Patients with central nervous system disorders that might affect the blood-brain barrier
Severe liver disease
Concurrent use of drugs known to significantly inhibit P-glycoprotein (without close monitoring)
Loiasis in areas with high Loa loa microfilarial loads
Certain eye conditions involving the retina or optic nerve
Hygiene Measures:
Wash hands thoroughly before eating and after using the bathroom
Keep fingernails short and clean
Avoid walking barefoot in endemic areas
Wash all fruits and vegetables thoroughly
Environmental Control:
Regularly wash bedding and clothing in hot water during treatment
Vacuum living areas thoroughly, especially when treating scabies or lice
Ensure proper sanitation and waste disposal to prevent reinfection
Diet Recommendations:
Maintain good nutrition to support immune function
Stay well-hydrated during treatment
A fatty meal before taking the medication may improve albendazole absorption
Post-Treatment Care:
Complete any household decontamination measures as recommended
Follow up with healthcare provider as advised to confirm cure
Consider family/household member screening and treatment when appropriate
Healthcare providers prescribe Bandy-Plus Chewable Tablet due to several key advantages:
Provides broad-spectrum coverage against multiple parasite types with a single formulation
Convenient single-dose therapy for many common parasitic infections
Particularly valuable in geographic regions with high prevalence of polyparasitism
Chewable formulation improves compliance, especially in pediatric populations
Effective for community-wide deworming programs
Combined mechanism of action may help prevent resistance development
Cost-effective approach to comprehensive parasite treatment
Proven efficacy in clinical trials and field applications
Particularly useful when diagnostic resources are limited and empiric therapy is necessary
Ivermectin tablets (various brands)
Albendazole tablets or suspension (various brands)
Mebendazole tablets for certain helminth infections
Pyrantel pamoate for specific roundworm infections
Praziquantel for tapeworm infections
Diethylcarbamazine for filarial infections
Region-specific combinations of antiparasitic medications
Fixed-dose combinations with different strength ratios
For prevention: improved sanitation and hygiene measures
Regular hand washing and nail hygiene
Proper food preparation and cooking practices
Clean water sources and water treatment
Community education on parasite transmission
Vector control measures where applicable
Store at room temperature (20-25°C or 68-77°F)
Keep away from direct sunlight and moisture
Store in the original package until time of use
Keep out of reach of children
Do not use after the expiration date
Do not refrigerate or freeze
Close container tightly after use
Common feedback from patients includes:
Effective resolution of symptoms in most cases
Some report mild and transient gastrointestinal discomfort
Convenience of single-dose therapy appreciated
Chewable formulation generally well-accepted, even by children
Some patients report temporary worsening of symptoms before improvement (likely due to parasite die-off)
Questions about need for repeat treatment or family treatment frequently arise
Concerns about environmental decontamination to prevent reinfection
Occasional reports of temporary dizziness or headache
Generally positive response regarding overall efficacy
Complete the full course of treatment as prescribed
Take measures to prevent reinfection (hand washing, hygiene, etc.)
Consider treating all household members simultaneously for highly contagious parasites
Notify your doctor of any other medications you are taking
Maintain good hydration during treatment
Chew tablet thoroughly before swallowing
Taking with food may help reduce stomach upset
Follow up with your healthcare provider if symptoms persist
Wash bedding and clothing in hot water during and after treatment for ectoparasites
Do not share personal items that may transmit parasites
Chemical Class: Macrocyclic lactone (Ivermectin) + Benzimidazole (Albendazole)
Habit Forming: No
Therapeutic Class: Antiparasitic, Anthelmintic
Action Class: Neuromuscular and metabolic inhibitors of parasites
Before or during treatment, your doctor may recommend:
Stool examination for ova and parasites
Skin scrapings (for scabies diagnosis)
Complete blood count (to check for eosinophilia or anemia)
Liver function tests
Serological tests for specific parasitic infections
In some cases, imaging studies for suspected tissue parasites
Follow-up stool examinations to confirm cure
World Health Organization Guidelines for the Treatment of Parasitic Infections
Clinical Infectious Disease Treatment Guidelines
Pharmacology references for antiparasitic medications
Clinical studies on combination therapy for parasitic infections
National treatment guidelines for neglected tropical diseases
Link to credible health sources:
This information is provided for educational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition or treatment. Never disregard professional medical advice or delay in seeking it because of information you have read here. This medication should only be used under the supervision of a qualified healthcare provider.